HealthTriglyceride-glucose index combined with DAS28-ESR predicts cardiovascular disease risk in patients with rheumatoid arthritis: a national multicenter cohort study October 28, 2026October 28, 2026 Chucky. Continue reading “Triglyceride-glucose index combined with DAS28-ESR predicts cardiovascular disease risk in patients with rheumatoid arthritis: a national multicenter cohort study” →
HealthNeutrophils and lipocalin-2 in triglyceride-glucose body mass index-related cardiometabolic risk among patients with rheumatoid arthritis: a multicenter study October 8, 2026October 8, 2026 Chucky. Continue reading “Neutrophils and lipocalin-2 in triglyceride-glucose body mass index-related cardiometabolic risk among patients with rheumatoid arthritis: a multicenter study” →
HealthAssociations of combined triglyceride-glucose and sarcopenia index with incident cardiovascular disease in middle-aged and older Chinese adults September 25, 2026September 25, 2026 Chucky. Continue reading “Associations of combined triglyceride-glucose and sarcopenia index with incident cardiovascular disease in middle-aged and older Chinese adults” →
HealthAssociation and predictive value of the C-reactive protein-triglyceride-glucose index in chronic kidney disease September 18, 2026September 18, 2026 Chucky. Continue reading “Association and predictive value of the C-reactive protein-triglyceride-glucose index in chronic kidney disease” →
HealthC reactive protein triglyceride glucose index is associated with incident cardiovascular disease in middle aged and older adults with arthritis September 13, 2026September 13, 2026 Chucky. Continue reading “C reactive protein triglyceride glucose index is associated with incident cardiovascular disease in middle aged and older adults with arthritis” →
HealthTriglyceride–cholesterol–body weight index and incident cardiovascular disease in cardiovascular-kidney-metabolic syndrome stages 0–3: a CHARLS cohort study September 12, 2026September 12, 2026 Chucky. Continue reading “Triglyceride–cholesterol–body weight index and incident cardiovascular disease in cardiovascular-kidney-metabolic syndrome stages 0–3: a CHARLS cohort study” →
